Evaluation of the Arabin cervical pessary for prevention of preterm birth in women with a twin pregnancy and short cervix (STOPPIT-2): An open-label randomised trial and updated meta-analysis

ConclusionsThese results led us to reject our hypothesis that the Arabin pessary would reduce the risk of the primary outcome by 40%. Smaller treatment effects cannot be ruled out. Trial registrationClinicalTrials.gov ISRCTN 02235181.ClinicalTrials.gov NCT02235181.
Source: PLoS Medicine - Category: Internal Medicine Authors: Source Type: research